Blake Borgeson
CIK 1856094 · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.44M
Companies
1
Total Filings
78
Lifetime Open-Market Net
-$10.04M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXRX | Director | 6,169,863 | $3.15 | $19.44M | -$10.04M | 78 | 2026-06-04 |
Recent Filings · Page 7 of 8
78 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-12 | RXRX | Sell (S) | −8,885 | -$68.3K | EDGAR |
| 2023-01-05 | RXRX | Grant (A) | +1,325 | $0 | EDGAR |
| 2022-12-29 | RXRX | Sell (S) | −8,885 | -$64.4K | EDGAR |
| 2022-12-15 | RXRX | Sell (S) | −8,885 | -$79.6K | EDGAR |
| 2022-12-01 | RXRX | Sell (S) | −8,885 | -$77.8K | EDGAR |
| 2022-11-18 | RXRX | Sell (S) | −17,770 | -$197.6K | EDGAR |
| 2022-10-05 | RXRX | Grant (A) | +920 | $0 | EDGAR |
| 2022-07-06 | RXRX | Grant (A) | +1,186 | $0 | EDGAR |
| 2022-06-16 | RXRX | Grant (A) | +18,145 | $0 | EDGAR |
| 2022-04-05 | RXRX | Grant (A) | +1,300 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.